A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study) - No Study Results Posted

Home Search Study Topics Glossary

A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study)

This study has been completed.

Study NCT00535028 Information provided by Aerovance, Inc.

First Received: September 21, 2007 No Changes Posted

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2005
Estimated Primary Completion Date:	No date given